Alvotech (ALVO) Share-based Compensation (2022 - 2026)

Alvotech (ALVO) posted Share-based Compensation of $2.3 million for Q1 2026, up 566.0% on a QoQ basis from -$503000.0 in Q4 2025, and up 79.2% year-over-year from $1.3 million in Q1 2025.

Alvotech (ALVO) Share-based Compensation (2022 - 2026) Analysis & Trends

Alvotech's Share-based Compensation history runs 5 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • Quarterly Share-based Compensation rose 79.2% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (up 37.8% YoY) and the FY2025 annual result came in at $7.4 million, down 3.25% from the prior year.
  • Share-based Compensation was $2.3 million for Q1 2026 at Alvotech, up from -$503000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.4 million in Q1 2023 and bottomed at -$503000.0 in Q4 2025.
  • A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2023 — Share-based Compensation jumped 253.95% — and 2024, when it sank 109.0%.
  • Alvotech's Share-based Compensation stood at $4.6 million in 2022, then plunged by 38.8% to $2.8 million in 2023, then plunged by 109.0% to -$255000.0 in 2024, then tumbled by 97.25% to -$503000.0 in 2025, then soared by 566.0% to $2.3 million in 2026.
  • Business Quant data shows ALVO's Share-based Compensation at $2.3 million in Q1 2026, -$503000.0 in Q4 2025, and $4.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 2.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.34 Mn
Mar 31, 2026 2.34 Mn
Dec 31, 2025 -503,000.00
Dec 31, 2025 -503,000.00
Sep 30, 2025 4.46 Mn
Sep 30, 2025 4.46 Mn
Jun 30, 2025 2.11 Mn
Jun 30, 2025 2.11 Mn
Mar 31, 2025 1.31 Mn
Mar 31, 2025 1.31 Mn
Dec 31, 2024 -255,000.00
Dec 31, 2024 -255,000.00
Sep 30, 2024 2.59 Mn
Sep 30, 2024 2.59 Mn
Jun 30, 2024 2.47 Mn
Jun 30, 2024 2.47 Mn
Mar 31, 2024 2.83 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 2.83 Mn
Dec 31, 2023 2.83 Mn